Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
מצבים רפואיים
Large B-cell Lymphoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
Contact: Principal Investigator (Matthew Ulrickson, MD)Genesis Cancer and Blood Institute, Hot Springs, Arkansas, United States
Contact: Principal Investigator (Stephen Divers, MD)Alta Bates Summit Medical Center, Berkeley, California, United States
Contact: Principal Investigator (Oleg Krijanovski, MD)City of Hope, Duarte, California, United States
Contact: Principal Investigator (Geoffrey Shouse, MD)Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Akil Merchant, MD)University of California, Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Sven DeVos, MD)University of California, Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Principal Investigator (Naseem Esteghamat, MD)University of California, San Diego, San Diego, California, United States
Contact: Principal Investigator (Ayad Hamdan, MD)University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Michael Spinner, MD)Rocky Mountain Cancer Centers, Denver, Colorado, United States
Contact: Principal Investigator (John Burke, MD)Medical Oncology Hematology Consultants, Newark, Delaware, United States
Contact: Principal Investigator (Jamal Misleh, MD)MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Kieron Dunleavy, MD)Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Contact: Principal Investigator (Yuliya Linhares, MD)Advent Health Cancer Institute, Orlando, Florida, United States
Contact: Principal Investigator (Rushang Patel, MD)Orlando Health Cancer Institute, Orlando, Florida, United States
Contact: Principal Investigator (Abhishek Chilkulwar, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Frederick Locke, MD)Augusta University Georgia Cancer Center, Augusta, Georgia, United States
Contact: Principal Investigator (Locke Bryan, MD)Northwestern University - Feinberg School of Medicine, Chicago, Illinois, United States
Contact: Principal Investigator (Reem Karmali, MD)Rush University Medical Center, Chicago, Illinois, United States
Contact: Principal Investigator (Sunita Nathan, MD)Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
Contact: Principal Investigator (Sunil Babu, MD)IU Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States
Contact: Principal Investigator (Varun Mittal, MD)Indiana Blood and Marrow Transplantation, Indianapolis, Indiana, United States
Contact: Principal Investigator (Anand Tandra, MD)The University of Kansas Hospital, Kansas City, Kansas, United States
University of Kentucky Medical Center, Lexington, Kentucky, United States
Contact: Principal Investigator (Chaitanya Iragavarapu, MD)University of Louisville Health Brown Cancer Center, Louisville, Kentucky, United States
Contact: Principal Investigator (Hassaan Yasin, MD)Norton Cancer Institute, Louisville, Kentucky, United States
Contact: Principal Investigator (Don Stevens, MD)University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Jean Yared, MD)The Center for Cancer and Blood Disorders, Bethesda, Maryland, United States
Contact: Principal Investigator (Ralph Boccia, MD)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Jeremy Abramson, MD)Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Michael Leukam, MD)University of Missouri - Ellis Fischel Cancer Center, Columbia, Missouri, United States
Contact: Principal Investigator (Gerhard Hildebrandt, MD)MidAmerica Cancer Care, Kansas City, Missouri, United States
Contact: Principal Investigator (Jaswinder Singh, MD)Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Contact: Principal Investigator (Nancy Bartlett, MD)Astera Cancer Care, East Brunswick, New Jersey, United States
Contact: Principal Investigator (Edward Licitra, MD)John Theurer Cancer Center, Hackensack, New Jersey, United States
Contact: Principal Investigator (Lori Leslie, MD)Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Contact: Principal Investigator (Matthew Matasar, MD)Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, United States
Contact: Principal Investigator (Ran Reshef, MD)University of Rochester Medical Center, Rochester, New York, United States
Contact: Principal Investigator (Patrick Reagan, MD)Novant Health Cancer Institute- Hematology, Charlotte, North Carolina, United States
Contact: Principal Investigator (Alan Skarbnik, MD)Duke Blood Cancer Center, Durham, North Carolina, United States
Contact: Principal Investigator (Mitchell Horwitz, MD)Oncology Hematology Care - Kenwood, Cincinnati, Ohio, United States
Contact: Principal Investigator (Ahmed Galal, MD)University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Tahir Latif, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Paolo Caimi, MD)Oncology Associates of Oregon, Eugene, Oregon, United States
Contact: Principal Investigator (Jeff Sharman, MD)Oregon Health and Science University, Portland, Oregon, United States
Contact: Principal Investigator (Richard Maziarz, MD)Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Rashmi Khanal, MD)West Penn Hospital, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Prerna Mewawalla, MD)Avera Cancer Institute, Sioux Falls, South Dakota, United States
Contact: Principal Investigator (Waqas Jehangir, MD)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Andrew Jallouk, MD)Texas Oncology - Central South, Austin, Texas, United States
Contact: Principal Investigator (Jason Melear, MD)Texas Oncology - Dallas Fort Worth, Dallas, Texas, United States
Contact: Principal Investigator (Houston Holmes, MD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jason Westin, MD)Texas Transplant Institute, San Antonio, Texas, United States
Contact: Principal Investigator (Nosha Farhadfar, MD)Texas Oncology - Tyler, Tyler, Texas, United States
Contact: Principal Investigator (Habte Yimer, MD)Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Lindsey Fitzgerald, MD)Intermountain Health LDS Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Bradley Hunter, MD)University of Virginia, Charlottesville, Virginia, United States
Contact: Principal Investigator (Indumathy Varadarajan, MD)Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Principal Investigator (Mitul Gandhi, MD)Virginia Oncology Associates - Norfolk, Norfolk, Virginia, United States
Contact: Principal Investigator (Gary Simmons, MD)Swedish Cancer Institute, Seattle, Washington, United States
Contact: Principal Investigator (Matthew Schwede, MD)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Principal Investigator (Ryan Lynch, MD)Icon Cancer Centre Wesley, Auchenflower, Queensland, Australia
Contact: Principal Investigator (Karthik Nath, MD)Royal Hobart Hospital, Hobart, Tasmania, Australia
Contact: Principal Investigator (Anna Johnston, MD)Monash Health, Clayton, Victoria, Australia
Contact: Principal Investigator (Danielle Oh, MD)St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
Contact: Principal Investigator (Matthew Ku, MD)Austin Health, Heidelberg, Victoria, Australia
Contact: Principal Investigator (Denise Lee, MD)Hollywood Private Hospital, Nedlands, Western Australia, Australia
Contact: Principal Investigator (Chan Cheah, MD)Arthur JE Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
Contact: Principal Investigator (Mona Shafey, MD)Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
Contact: Principal Investigator (Mahmoud Elsawy, MD)Princess Margaret Cancer Centre - University Health Network, Toronto, Ontario, Canada
Contact: Principal Investigator (John Kuruvilla, MD)Centre Integre Universitaire de Sante et Services Sociaux de L'Est de I'lle de Montreal / installation Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada
Contact: Principal Investigator (Sandra Cohen, MD)CHUM - University of Montreal Hospital Centre, Montreal, Quebec, Canada
Contact: Principal Investigator (Xavier Deschenes-Simard, MD)Hopital de'L'Enfant-Jesus, Québec, Quebec, Canada
Contact: Principal Investigator (Christopher Lemieux, MD)Pusan National University Hospital, Seogu, Busan, South Korea
Contact: Principal Investigator (Shin Ho-jin, MD)Samsung Medical Center, Gangnam-gu, Seoul, South Korea
Contact: Principal Investigator (Seok Kim, MD)Seoul National University, Jongno-gu, Seoul, South Korea
Contact: Principal Investigator (Youngil Koh, MD)Asan Medical Center, Songpa-gu, Seoul, South Korea
Contact: Principal Investigator (Dok Yoon, MD)
מובילי המחקר
Allogene Study Director
Study Director
Allogene Therapeutics, Inc.